DELSTRIGO cpr pellic 100 mg 30 pce

7680670660013 CH-67066 J05AR24 08.03.0.
DELSTRIGO cpr pellic 100 mg 30 pce
DELSTRIGO cpr pellic 100 mg 30 pce
DELSTRIGO cpr pellic 100 mg 30 pce
1 / 3
google

Details

Product number
6706601
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
doravirinum 100 mg, lamivudinum 300 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili fumaras 300 mg, hypromellosi acetas succinas, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, natrii stearylis fumaras, Überzug: hypromellosum, lactosum monohydricum 8.58 mg, triacetinum, cera carnauba, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.22 mg.

Articles (1)

Delstrigo, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/09/2025
Patient information leaflet
Français
13/09/2025
Patient information leaflet
Italien
13/09/2025
Professional SmPC
Allemand
13/09/2025
Professional SmPC
Français
13/09/2025
Professional SmPC
Italien
13/09/2025

Detailed composition

Substance Quantity Type Category
doravirinum
100.0 MG Substance Wirkstoff (Principe actif)
lamivudinum
300.0 MG Substance Wirkstoff (Principe actif)
tenofovirum disoproxilum
245.0 MG Substance Wirkstoff (Principe actif)
tenofoviri disoproxili fumaras
300.0 MG Substance WIZUS
hypromellosi acetas succinas
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
hypromellosum
- Substance HNIDK
lactosum monohydricum
8.58 MG Substance HBESI
triacetinum
- Substance HNIDK
cera carnauba
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
natrium
0.22 MG Substance HBESI

Reimbursement information

Public price
CHF 699.95
Specialties list
Yes
Generic
No
SL addition date: 01/03/2020

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
67066
Drug name
Delstrigo, Filmtabletten
Galenic form
FILM
ATC Code
J05AR24
Authorization status
Z
Dispensation category
A
First authorization
17/12/2019
Authorization expiration date
31/12/9999
IT number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektion

Packaging details

Description (FR)
DELSTRIGO cpr pellic 100 mg 30 pce
Description (DE)
DELSTRIGO Filmtabl 100 mg 30 Stk
Market launch
17/12/2019
Narcotic (BTM)
No
Buy us a coffee Explore the data